NCT02147418Completed
Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
An Observational, Single-Institution Pilot/Feasibility Study of Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
Source: ClinicalTrials.gov · Last updated 22 May 2025
Brief summary (registry, in English)
Cancer of the oropharynx (middle, side and back walls of the throat; back of the tongue; soft palate, and tonsils), or oropharyngeal squamous cell carcinoma (OPSCC), has been on the rise in the United States. Human papillomavirus (HPV) has been recognized in many of these cancers, and testing for HPV has contributed to the higher reported rates of OPSCC. In this study, our goal is to develop a new test that can detect certain HPV proteins in the blood or saliva to help improve detection of OPSCC.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 15 (actual)
- First submitted
- 22 May 2014
- Start date
- 25 Feb 2015
- Primary completion date
- 8 May 2024
- Lead sponsor
- New Mexico Cancer Research Alliance
- Diseases
- Head and neck cancer
- NCT number
- NCT02147418
What you commit to
- Study type: Observational
- Participants enrolled: 15
- From 25 Feb 2015 to the primary completion date, 8 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age less than 18 years
Other
- Prisoners
- Pregnant women
- Patients with mental disability
Who the study is looking for
- Male or Female
- Age greater than or equal to 18
- Previously untreated, pathologically confirmed OPSCC (HPV+ or HPV-)
- Ability to understand study information and provide written consent for participation.
- Male or Female
- Age greater than or equal to 18
- Ability to understand study information and provide written consent for participation
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of New Mexico Cancer Center Coordinator of this site? Confirm its status | Albuquerque | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.